Identification and investigation of RNA-binding ligands
Richardson, Stacie
Loading…
Permalink
https://hdl.handle.net/2142/42196
Description
Title
Identification and investigation of RNA-binding ligands
Author(s)
Richardson, Stacie
Issue Date
2013-02-03T19:27:34Z
Director of Research (if dissertation) or Advisor (if thesis)
Baranger, Anne M.
Doctoral Committee Chair(s)
Baranger, Anne M.
Committee Member(s)
Zimmerman, Steven C.
Katzenellenbogen, John A.
van der Donk, Wilfred A.
Department of Study
Chemistry
Discipline
Chemistry
Degree Granting Institution
University of Illinois at Urbana-Champaign
Degree Name
Ph.D.
Degree Level
Dissertation
Keyword(s)
RNA
Ligand
MBNL1
myotonic dystrophy
trinucleotide repeats
CUG repeats
Abstract
Myotonic dystrophy type 1 is caused by a toxic CUG RNA repeat expansion in the 3’-UTR of the DMPK gene that sequesters a key splicing regulator, MBNL1, preventing normal modulation of alternative splicing of a variety of genes. Targeting these repeats with small molecules could block the sequestration of MBNL1 and restore normal splicing levels, alleviating the pathogenesis of the disease. To that end, I have screened a library of select compounds, chosen for their potential to act as RNA binding ligands. From the initial screen, I identified several promising lead compounds. I proceeded to perform a structure-activity relationship (SAR) study on one of the lead molecules, NSC657704. Based on the results of the SAR, I designed a set of derivatives, synthesized them, and ascertained their inhibitory activity and RNA binding affinity.
Use this login method if you
don't
have an
@illinois.edu
email address.
(Oops, I do have one)
IDEALS migrated to a new platform on June 23, 2022. If you created
your account prior to this date, you will have to reset your password
using the forgot-password link below.